GLIPIZIDE

GLIPIZIDE was reported 61010 times

GLIPIZIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 89 0.0838
1 NEPHROGENIC ANAEMIA 325 0.0701
2 HYPERPARATHYROIDISM SECONDARY 164 0.0654
3 BLADDER TRANSITIONAL CELL CARCINOMA 77 0.0537
4 EARLY SATIETY 99 0.0508
5 DIABETIC NEUROPATHY 234 0.0472
6 BLOOD GLUCOSE DECREASED 2246 0.0467
7 ISCHAEMIC CARDIOMYOPATHY 130 0.0424
8 BLOOD GLUCOSE FLUCTUATION 451 0.0411
9 GASTROINTESTINAL HYPOMOTILITY 90 0.0399
10 ESSENTIAL HYPERTENSION 72 0.0393
11 REBOUND ACID HYPERSECRETION 117 0.0386
12 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 46 0.0384
13 BLOOD GLUCOSE INCREASED 6719 0.0356
14 GLYCOSYLATED HAEMOGLOBIN INCREASED 893 0.0353
15 DIABETES MELLITUS INADEQUATE CONTROL 615 0.0347
16 END STAGE RENAL DISEASE 584 0.0320
17 MEDICATION RESIDUE 78 0.0302
18 BLADDER CANCER RECURRENT 30 0.0301
19 IMPAIRED GASTRIC EMPTYING 401 0.0294
20 GLYCOSYLATED HAEMOGLOBIN DECREASED 47 0.0292
21 DILATATION ATRIAL 33 0.0283
22 HEART INJURY 70 0.0281
23 HYPOGLYCAEMIA 1335 0.0275
24 ADENOCARCINOMA PANCREAS 35 0.0272
25 LEFT ATRIAL DILATATION 34 0.0266
26 PANCREATIC CARCINOMA METASTATIC 73 0.0256
27 HAEMORRHAGIC ANAEMIA 112 0.0255
28 DIABETIC RETINOPATHY 84 0.0247
29 BLOOD GLUCOSE ABNORMAL 452 0.0244
30 CORONARY ARTERY DISEASE 718 0.0237
31 DIABETIC NEPHROPATHY 52 0.0236
32 DIABETES MELLITUS NON-INSULIN-DEPENDENT 34 0.0234
33 CHRONIC KIDNEY DISEASE 1649 0.0217
34 DIABETIC COMPLICATION 55 0.0216
35 HYPOGLYCAEMIC COMA 62 0.0215
36 COLONIC POLYP 35 0.0212
37 STOMACH DISCOMFORT 104 0.0201
38 OCCULT BLOOD POSITIVE 39 0.0198
39 PERIPHERAL VASCULAR DISORDER 102 0.0198
40 HYPERTENSIVE HEART DISEASE 37 0.0198
41 INJECTION SITE NODULE 210 0.0191
42 RENAL FAILURE CHRONIC 146 0.0190
43 THERAPEUTIC AGENT TOXICITY 62 0.0186
44 HYPERLIPIDAEMIA 218 0.0182
45 DIABETIC COMA 51 0.0182
46 CARDIAC FAILURE CONGESTIVE 1459 0.0181
47 RENAL INJURY 516 0.0174
48 DIABETIC FOOT 53 0.0173
49 HYPOGLYCAEMIC UNCONSCIOUSNESS 33 0.0166
50 CAROTID ARTERY STENOSIS 58 0.0166
51 ORAL INTAKE REDUCED 40 0.0165
52 DIASTOLIC DYSFUNCTION 51 0.0165
53 ARTERIOSCLEROSIS CORONARY ARTERY 109 0.0164
54 ARTERIOSCLEROSIS 147 0.0156
55 VENTRICULAR HYPERTROPHY 39 0.0155
56 AORTIC ARTERIOSCLEROSIS 40 0.0155
57 EUGLYCAEMIC DIABETIC KETOACIDOSIS 64 0.0155
58 AORTIC STENOSIS 53 0.0152
59 LEFT VENTRICULAR HYPERTROPHY 65 0.0152
60 MYOCARDIAL ISCHAEMIA 172 0.0151
61 ANOREXIA 192 0.0149
62 ANGINA UNSTABLE 96 0.0148
63 DIABETES MELLITUS 1112 0.0146
64 ORTHOPNOEA 45 0.0141
65 TYPE 1 DIABETES MELLITUS 83 0.0138
66 BENIGN PROSTATIC HYPERPLASIA 71 0.0137
67 MITRAL VALVE INCOMPETENCE 154 0.0136
68 ERUCTATION 263 0.0136
69 TYPE 2 DIABETES MELLITUS 456 0.0135
70 CORONARY ARTERY STENOSIS 68 0.0135
71 HIGH DENSITY LIPOPROTEIN DECREASED 45 0.0135
72 MULTIPLE INJURIES 85 0.0135
73 BLADDER CANCER 794 0.0135
74 DIFFICULTY IN WALKING 46 0.0134
75 DIVERTICULUM 95 0.0134
76 SUSPECTED SUICIDE 62 0.0132
77 MEDICATION RESIDUE PRESENT 63 0.0132
78 CORONARY ARTERY OCCLUSION 181 0.0132
79 TRICUSPID VALVE INCOMPETENCE 104 0.0131
80 PHARYNGOLARYNGEAL PAIN 69 0.0130
81 DIABETIC KETOACIDOSIS 307 0.0128
82 ECONOMIC PROBLEM 190 0.0125
83 LOWER GASTROINTESTINAL HAEMORRHAGE 92 0.0124
84 DIVERTICULUM INTESTINAL 54 0.0123
85 RENAL FAILURE ACUTE 524 0.0123
86 RENAL FAILURE 1623 0.0122
87 TOE AMPUTATION 62 0.0122
88 AORTIC VALVE INCOMPETENCE 51 0.0120
89 INJECTION SITE EXTRAVASATION 145 0.0117
90 SPINAL COLUMN STENOSIS 55 0.0116
91 BLOOD CHLORIDE DECREASED 30 0.0116
92 FEELING JITTERY 221 0.0116
93 ACUTE CORONARY SYNDROME 96 0.0116
94 NEPHROGENIC SYSTEMIC FIBROSIS 35 0.0116
95 CAROTID ARTERY OCCLUSION 42 0.0115
96 HYPERGLYCAEMIA 418 0.0115
97 PSYCHOLOGICAL TRAUMA 98 0.0113
98 METABOLIC ENCEPHALOPATHY 34 0.0113
99 DYSLIPIDAEMIA 57 0.0112
100 PROSTATOMEGALY 44 0.0112
101 NEPHROPATHY 103 0.0110
102 BLOOD POTASSIUM INCREASED 178 0.0110
103 NON-CARDIAC CHEST PAIN 34 0.0107
104 ATELECTASIS 103 0.0106
105 GOUT 190 0.0106
106 CARDIOMEGALY 130 0.0106
107 HAIR DISORDER 87 0.0105
108 CARDIOMYOPATHY 156 0.0105
109 RENAL TUBULAR NECROSIS 103 0.0105
110 ACUTE MYOCARDIAL INFARCTION 309 0.0105
111 SPINAL OSTEOARTHRITIS 92 0.0105
112 RENAL CYST 83 0.0104
113 BUNDLE BRANCH BLOCK LEFT 44 0.0104
114 PANCREATITIS 545 0.0103
115 MENTAL STATUS CHANGES 286 0.0103
116 ACUTE KIDNEY INJURY 1560 0.0102
117 BODY HEIGHT DECREASED 109 0.0102
118 LEG AMPUTATION 42 0.0102
119 WEIGHT DECREASED 2839 0.0102
120 PANCREATITIS ACUTE 224 0.0100
121 INTERVERTEBRAL DISC DEGENERATION 92 0.0099
122 LACTIC ACIDOSIS 320 0.0099
123 GANGRENE 58 0.0096
124 CONGESTIVE CARDIOMYOPATHY 40 0.0096
125 VISUAL DISTURBANCE 55 0.0096
126 UPPER GASTROINTESTINAL HAEMORRHAGE 161 0.0096
127 INTENTIONAL DEVICE MISUSE 42 0.0095
128 ANHEDONIA 250 0.0095
129 HYPERKERATOSIS 52 0.0094
130 ABSCESS LIMB 40 0.0094
131 SLEEP APNOEA SYNDROME 178 0.0093
132 MYOCARDIAL INFARCTION 1625 0.0093
133 STENT PLACEMENT 75 0.0093
134 ARTERIAL OCCLUSIVE DISEASE 73 0.0093
135 CEREBRAL ATROPHY 37 0.0093
136 CARDIAC MURMUR 80 0.0092
137 FAILURE TO THRIVE 48 0.0092
138 NOCTURIA 112 0.0092
139 TUBULOINTERSTITIAL NEPHRITIS 172 0.0092
140 BUNDLE BRANCH BLOCK RIGHT 42 0.0091
141 PANCREATIC DISORDER 45 0.0091
142 CATARACT OPERATION 54 0.0091
143 ENERGY INCREASED 53 0.0090
144 HUNGER 125 0.0090
145 BLOOD UREA INCREASED 150 0.0089
146 HYPOVOLAEMIA 52 0.0089
147 ABNORMAL LOSS OF WEIGHT 60 0.0088
148 WEIGHT FLUCTUATION 92 0.0088
149 HAIR COLOUR CHANGES 109 0.0088
150 CARDIAC PACEMAKER INSERTION 52 0.0087
151 PRODUCT SOLUBILITY ABNORMAL 44 0.0087
152 DECREASED APPETITE 2022 0.0087
153 BLOOD TRIGLYCERIDES INCREASED 153 0.0087
154 DECUBITUS ULCER 70 0.0086
155 BLOOD MAGNESIUM DECREASED 74 0.0086
156 IRON DEFICIENCY ANAEMIA 79 0.0085
157 CARDIAC FAILURE ACUTE 57 0.0085
158 GOITRE 35 0.0085
159 ATRIOVENTRICULAR BLOCK FIRST DEGREE 37 0.0085
160 TRANSIENT ISCHAEMIC ATTACK 286 0.0085
161 OBESITY 133 0.0083
162 ABDOMINAL HERNIA 38 0.0083
163 RHINITIS ALLERGIC 37 0.0083
164 RIGHT VENTRICULAR FAILURE 58 0.0083
165 HYPERKALAEMIA 290 0.0083
166 BLOOD CHOLESTEROL ABNORMAL 38 0.0082
167 PROTHROMBIN TIME PROLONGED 49 0.0082
168 CORONARY ARTERY BYPASS 47 0.0082
169 FLATULENCE 459 0.0081
170 CORONARY ARTERIAL STENT INSERTION 41 0.0081
171 PHARMACEUTICAL PRODUCT COMPLAINT 210 0.0081
172 DYSPEPSIA 792 0.0080
173 POLLAKIURIA 335 0.0080
174 POOR PERIPHERAL CIRCULATION 34 0.0080
175 LEFT VENTRICULAR DYSFUNCTION 53 0.0079
176 MACULAR OEDEMA 44 0.0078
177 FLUID OVERLOAD 114 0.0078
178 INJECTION SITE HAEMORRHAGE 625 0.0078
179 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 408 0.0078
180 PRODUCT RESIDUE PRESENT 42 0.0078
181 DRUG EFFECT DECREASED 417 0.0077
182 CELLULITIS 389 0.0077
183 INTERNAL HAEMORRHAGE 88 0.0077
184 GASTROINTESTINAL HAEMORRHAGE 643 0.0077
185 GASTROOESOPHAGEAL REFLUX DISEASE 619 0.0077
186 LARGE INTESTINE POLYP 53 0.0076
187 ATRIAL FLUTTER 61 0.0076
188 ACCIDENTAL UNDERDOSE 110 0.0076
189 ACUTE RESPIRATORY FAILURE 147 0.0076
190 FLUID RETENTION 388 0.0076
191 HAEMATOCRIT DECREASED 151 0.0076
192 LUNG INFILTRATION 67 0.0076
193 INJECTION SITE MASS 279 0.0075
194 ESCHERICHIA URINARY TRACT INFECTION 32 0.0075
195 MYOPATHY 65 0.0075
196 MULTIPLE MYELOMA 35 0.0075
197 HAEMODIALYSIS 63 0.0075
198 LACERATION 70 0.0074
199 RENAL DISORDER 346 0.0074
200 PULSELESS ELECTRICAL ACTIVITY 31 0.0074
201 BLOOD CHOLESTEROL INCREASED 345 0.0074
202 ISCHAEMIA 34 0.0074
203 PULMONARY HYPERTENSION 154 0.0074
204 COAGULOPATHY 123 0.0074
205 HAEMORRHOIDAL HAEMORRHAGE 36 0.0074
206 INTERNATIONAL NORMALISED RATIO INCREASED 210 0.0074
207 EYE HAEMORRHAGE 98 0.0073
208 OEDEMA PERIPHERAL 892 0.0073
209 HAIR TEXTURE ABNORMAL 97 0.0072
210 INCREASED UPPER AIRWAY SECRETION 37 0.0072
211 URINE OUTPUT DECREASED 63 0.0072
212 REFUSAL OF TREATMENT BY PATIENT 47 0.0072
213 CARDIAC VALVE DISEASE 41 0.0072
214 COMPLETED SUICIDE 596 0.0071
215 OSTEOMYELITIS 129 0.0071
216 ONYCHOMYCOSIS 31 0.0071
217 FLANK PAIN 66 0.0070
218 ATRIAL FIBRILLATION 683 0.0070
219 ELECTROCARDIOGRAM ABNORMAL 55 0.0070
220 CATHETERISATION CARDIAC 31 0.0070
221 ANGINA PECTORIS 200 0.0070
222 MALNUTRITION 78 0.0070
223 HYPOPHAGIA 177 0.0069
224 SINUS TACHYCARDIA 98 0.0069
225 EXOSTOSIS 63 0.0069
226 HIATUS HERNIA 89 0.0069
227 GASTRITIS EROSIVE 32 0.0069
228 HYPERCHOLESTEROLAEMIA 66 0.0068
229 VISUAL ACUITY REDUCED 227 0.0068
230 DEHYDRATION 910 0.0068
231 DYSURIA 251 0.0068
232 POSTOPERATIVE WOUND INFECTION 46 0.0068
233 ACIDOSIS 52 0.0068
234 HYPERCHLORHYDRIA 40 0.0068
235 PAROSMIA 51 0.0068
236 INABILITY TO AFFORD MEDICATION 67 0.0067
237 CHOLELITHIASIS 221 0.0067
238 POST-TRAUMATIC STRESS DISORDER 45 0.0067
239 KETOACIDOSIS 50 0.0067
240 HAEMORRHOIDS 130 0.0067
241 GASTRITIS 175 0.0066
242 VENTRICULAR EXTRASYSTOLES 69 0.0066
243 FUNGAL INFECTION 221 0.0066
244 POLYURIA 54 0.0066
245 DYSPNOEA EXERTIONAL 248 0.0066
246 CARDIOVASCULAR DISORDER 167 0.0066
247 LOCALISED INFECTION 159 0.0066
248 HAEMATURIA 225 0.0066
249 ECCHYMOSIS 45 0.0066
250 EJECTION FRACTION DECREASED 102 0.0066
251 CEREBROVASCULAR ACCIDENT 1111 0.0066
252 ROTATOR CUFF SYNDROME 84 0.0065
253 OVERWEIGHT 35 0.0065
254 ERECTILE DYSFUNCTION 167 0.0065
255 BLOOD IRON DECREASED 77 0.0065
256 BLOOD PRESSURE INADEQUATELY CONTROLLED 39 0.0065
257 FAECAL INCONTINENCE 31 0.0064
258 DECREASED INTEREST 38 0.0064
259 FEAR 173 0.0064
260 CONSTIPATION 1399 0.0064
261 UROSEPSIS 59 0.0064
262 SKIN ULCER 165 0.0064
263 ATRIOVENTRICULAR BLOCK 49 0.0063
264 INCREASED APPETITE 121 0.0063
265 BLOOD TESTOSTERONE DECREASED 43 0.0063
266 AMMONIA INCREASED 32 0.0063
267 INTERVERTEBRAL DISC PROTRUSION 137 0.0063
268 ABDOMINAL TENDERNESS 31 0.0062
269 HEART RATE IRREGULAR 141 0.0062
270 CARPAL TUNNEL SYNDROME 87 0.0062
271 HEPATOMEGALY 61 0.0062
272 BLOOD SODIUM DECREASED 117 0.0062
273 INCOHERENT 40 0.0062
274 AORTIC ANEURYSM 47 0.0062
275 NERVE COMPRESSION 57 0.0062
276 UNRESPONSIVE TO STIMULI 159 0.0062
277 MAJOR DEPRESSION 45 0.0062
278 BLOOD CREATININE INCREASED 402 0.0062
279 BACK DISORDER 100 0.0061
280 DIALYSIS 87 0.0061
281 COLD SWEAT 108 0.0061
282 MADAROSIS 71 0.0061
283 HICCUPS 50 0.0061
284 HEPATIC CIRRHOSIS 114 0.0061
285 BLOOD URINE PRESENT 115 0.0061
286 OEDEMA 328 0.0060
287 VENTRICULAR FIBRILLATION 67 0.0060
288 NEPHROLITHIASIS 276 0.0060
289 HEARING IMPAIRED 36 0.0060
290 PROSTATIC DISORDER 33 0.0060
291 HEPATIC STEATOSIS 111 0.0060
292 MULTI-ORGAN FAILURE 103 0.0060
293 URINARY INCONTINENCE 176 0.0059
294 PULMONARY MASS 88 0.0059
295 CATARACT 351 0.0059
296 CARDIAC FLUTTER 38 0.0059
297 VENTRICULAR TACHYCARDIA 97 0.0059
298 LEUKOCYTOSIS 106 0.0059
299 SMALL INTESTINAL OBSTRUCTION 72 0.0058
300 CHEST PAIN 1083 0.0058
301 FAECALOMA 32 0.0058
302 CARDIAC DISORDER 544 0.0058
303 BLOOD ALBUMIN DECREASED 46 0.0058
304 BIPOLAR DISORDER 63 0.0058
305 NAUSEA 4586 0.0058
306 LIMB INJURY 157 0.0058
307 MUSCLE STRAIN 50 0.0058
308 MICTURITION URGENCY 66 0.0058
309 LIPASE INCREASED 44 0.0057
310 INJECTION SITE IRRITATION 73 0.0057
311 EXERCISE TOLERANCE DECREASED 33 0.0057
312 OSTEOARTHRITIS 243 0.0057
313 RETCHING 122 0.0057
314 ABASIA 141 0.0057
315 ABDOMINAL DISTENSION 595 0.0057
316 ASTHENIA 2138 0.0057
317 RECTAL HAEMORRHAGE 243 0.0057
318 INJECTION SITE BRUISING 451 0.0056
319 POLYP 37 0.0056
320 HYPOXIA 199 0.0056
321 PULMONARY OEDEMA 253 0.0056
322 INTESTINAL ISCHAEMIA 31 0.0056
323 GLAUCOMA 108 0.0056
324 ACTIVITIES OF DAILY LIVING IMPAIRED 111 0.0056
325 PROSTATIC SPECIFIC ANTIGEN INCREASED 77 0.0056
326 DECREASED ACTIVITY 60 0.0056
327 CYSTITIS 177 0.0056
328 URINARY TRACT INFECTION 948 0.0056
329 ILEUS 69 0.0055
330 INJURY 390 0.0055
331 RENAL IMPAIRMENT 465 0.0055
332 ANGIOPATHY 31 0.0055
333 TREATMENT NONCOMPLIANCE 302 0.0055
334 BLOOD CALCIUM DECREASED 62 0.0055
335 PLEURAL EFFUSION 335 0.0055
336 NERVOUSNESS 287 0.0055
337 HYPERSOMNIA 157 0.0055
338 BRONCHITIS 405 0.0055
339 CARDIAC OPERATION 47 0.0055
340 HOSPICE CARE 54 0.0055
341 HYPERTRIGLYCERIDAEMIA 32 0.0055
342 BLINDNESS UNILATERAL 77 0.0055
343 FULL BLOOD COUNT DECREASED 110 0.0055
344 CHOLECYSTITIS 65 0.0055
345 EMPHYSEMA 55 0.0054
346 RIB FRACTURE 112 0.0054
347 URINE ODOUR ABNORMAL 32 0.0054
348 DRUG TOXICITY 74 0.0054
349 JOINT INJURY 116 0.0054
350 SKIN LACERATION 59 0.0054
351 RHABDOMYOLYSIS 226 0.0054
352 WEIGHT INCREASED 1211 0.0054
353 VITREOUS FLOATERS 53 0.0054
354 HAEMORRHAGIC STROKE 42 0.0054
355 THIRST 96 0.0054
356 GLOMERULAR FILTRATION RATE DECREASED 66 0.0054
357 TREMOR 890 0.0054
358 HYPERHIDROSIS 689 0.0053
359 RETINAL HAEMORRHAGE 38 0.0053
360 BACK INJURY 58 0.0053
361 LOCAL SWELLING 93 0.0053
362 SEASONAL ALLERGY 75 0.0053
363 DIARRHOEA 3420 0.0053
364 RENAL PAIN 56 0.0053
365 ORAL PAIN 118 0.0053
366 TROPONIN INCREASED 40 0.0053
367 BLOOD POTASSIUM DECREASED 158 0.0052
368 HYPERTENSION 1111 0.0052
369 DRUG DOSE OMISSION 864 0.0052
370 DYSGEUSIA 388 0.0052
371 INCREASED TENDENCY TO BRUISE 48 0.0052
372 SCIATICA 83 0.0052
373 SLUGGISHNESS 53 0.0052
374 PERICARDIAL EFFUSION 120 0.0052
375 COLITIS ISCHAEMIC 35 0.0052
376 STAPHYLOCOCCAL INFECTION 171 0.0052
377 NEUROPATHY PERIPHERAL 492 0.0052
378 ULCER HAEMORRHAGE 35 0.0052
379 HEMIPLEGIA 43 0.0052
380 ABDOMINAL PAIN UPPER 1063 0.0052
381 METABOLIC ACIDOSIS 165 0.0052
382 DYSSTASIA 150 0.0051
383 SUPRAVENTRICULAR TACHYCARDIA 49 0.0051
384 BOWEL MOVEMENT IRREGULARITY 39 0.0051
385 TOOTH INFECTION 67 0.0051
386 FURUNCLE 40 0.0050
387 GALLBLADDER DISORDER 90 0.0050
388 MENISCUS INJURY 31 0.0050
389 FALL 1675 0.0050
390 FAECES DISCOLOURED 109 0.0050
391 DIVERTICULITIS 139 0.0050
392 ANAEMIA 954 0.0050
393 VISION BLURRED 686 0.0050
394 DIZZINESS 2488 0.0050
395 SENSORY LOSS 40 0.0050
396 HAEMOGLOBIN DECREASED 508 0.0049
397 ORTHOSTATIC HYPOTENSION 86 0.0049
398 ATRIOVENTRICULAR BLOCK COMPLETE 33 0.0049
399 HEPATIC ENCEPHALOPATHY 46 0.0049
400 GENERALISED OEDEMA 61 0.0049
401 LYMPHOEDEMA 34 0.0049
402 MEDICATION ERROR 273 0.0049
403 PEMPHIGOID 37 0.0049
404 PRURITUS GENERALISED 106 0.0049
405 RESPIRATORY FAILURE 357 0.0049
406 EPISTAXIS 366 0.0049
407 VOMITING 2291 0.0049
408 FLUSHING 494 0.0049
409 ARTHROPOD BITE 36 0.0049
410 NERVE INJURY 54 0.0049
411 PULMONARY CONGESTION 64 0.0048
412 WOUND INFECTION 53 0.0048
413 BLADDER DISORDER 48 0.0048
414 WRONG DRUG ADMINISTERED 43 0.0048
415 INCONTINENCE 51 0.0048
416 ABDOMINAL DISCOMFORT 808 0.0048
417 PRODUCT DOSE OMISSION 314 0.0048
418 BACTERAEMIA 57 0.0048
419 TENDERNESS 50 0.0048
420 SPLENOMEGALY 56 0.0048
421 BONE DISORDER 87 0.0048
422 BACK PAIN 1109 0.0048
423 INJECTION SITE DISCOMFORT 50 0.0047
424 MUSCULOSKELETAL PAIN 249 0.0047
425 SUBDURAL HAEMATOMA 68 0.0047
426 FOOT FRACTURE 90 0.0047
427 DIZZINESS POSTURAL 46 0.0047
428 SEPSIS 529 0.0047
429 FEELING COLD 132 0.0047
430 GASTRIC ULCER 90 0.0047
431 MUSCULOSKELETAL CHEST PAIN 73 0.0047
432 ORAL CANDIDIASIS 62 0.0047
433 DEFORMITY 44 0.0047
434 HAEMOPTYSIS 131 0.0047
435 LETHARGY 270 0.0047
436 MACULAR DEGENERATION 56 0.0047
437 RED BLOOD CELL COUNT DECREASED 134 0.0047
438 BLOOD COUNT ABNORMAL 71 0.0047
439 ARTHRITIS 368 0.0047
440 HEAD INJURY 148 0.0047
441 HYPOMAGNESAEMIA 65 0.0047
442 RESPIRATION ABNORMAL 32 0.0046
443 KIDNEY INFECTION 91 0.0046
444 TOOTH ABSCESS 47 0.0046
445 AGEUSIA 115 0.0046
446 NODULE 60 0.0046
447 MULTIPLE ALLERGIES 36 0.0046
448 MUSCULOSKELETAL DISCOMFORT 79 0.0046
449 MASS 64 0.0046
450 HYPOAESTHESIA ORAL 69 0.0046
451 CARDIO-RESPIRATORY ARREST 191 0.0046
452 UPPER LIMB FRACTURE 91 0.0046
453 BALANCE DISORDER 394 0.0046
454 ANAL INCONTINENCE 41 0.0046
455 PAIN IN EXTREMITY 1341 0.0045
456 PHARYNGEAL OEDEMA 70 0.0045
457 OSTEOPENIA 69 0.0045
458 SINUS DISORDER 90 0.0045
459 THYROID DISORDER 70 0.0045
460 TOOTH FRACTURE 50 0.0045
461 POST PROCEDURAL COMPLICATION 87 0.0045
462 THROMBOSIS 364 0.0045
463 CHROMATURIA 102 0.0045
464 LABORATORY TEST ABNORMAL 133 0.0045
465 HYPOACUSIS 194 0.0045
466 UPPER RESPIRATORY TRACT INFECTION 208 0.0045
467 HEMIPARESIS 76 0.0045
468 HAEMORRHAGE INTRACRANIAL 67 0.0045
469 DEPRESSION 1019 0.0045
470 ARRHYTHMIA 212 0.0045
471 ANKLE FRACTURE 69 0.0045
472 CONTUSION 427 0.0044
473 PROCEDURAL COMPLICATION 34 0.0044
474 PANCREATIC CARCINOMA 128 0.0044
475 EYE INFECTION 50 0.0044
476 PERIPHERAL SWELLING 682 0.0044
477 UNDERDOSE 323 0.0044
478 CONFUSIONAL STATE 715 0.0044
479 INJECTION SITE HAEMATOMA 64 0.0044
480 VITAMIN D DEFICIENCY 43 0.0044
481 NECK PAIN 246 0.0044
482 PRESYNCOPE 107 0.0044
483 TRANSFUSION 46 0.0044
484 DRUG DISPENSING ERROR 67 0.0044
485 GASTROENTERITIS VIRAL 79 0.0044
486 MOUTH HAEMORRHAGE 32 0.0044
487 DYSPNOEA 2460 0.0043
488 DISORIENTATION 172 0.0043
489 CLOSTRIDIUM DIFFICILE COLITIS 46 0.0043
490 GROIN PAIN 38 0.0043
491 FEELING HOT 265 0.0043
492 WRONG TECHNIQUE IN DRUG USAGE PROCESS 157 0.0043
493 RASH PRURITIC 234 0.0043
494 ISCHAEMIC STROKE 77 0.0043
495 FEELING DRUNK 32 0.0043
496 HEART RATE DECREASED 151 0.0043
497 BLOOD PRESSURE INCREASED 657 0.0043
498 SCAB 49 0.0043
499 HEART RATE INCREASED 425 0.0043
500 GAIT DISTURBANCE 821 0.0043
501 CARDIAC ARREST 354 0.0043
502 UNEVALUABLE EVENT 323 0.0043
503 LIGAMENT SPRAIN 42 0.0042
504 COLON CANCER 63 0.0042
505 MYELODYSPLASTIC SYNDROME 61 0.0042
506 RESPIRATORY TRACT CONGESTION 67 0.0042
507 BLINDNESS TRANSIENT 31 0.0042
508 LIMB DISCOMFORT 130 0.0042
509 TOOTHACHE 76 0.0042
510 HERNIA 81 0.0042
511 MUSCLE SPASMS 768 0.0042
512 FEELING ABNORMAL 1002 0.0042
513 GASTROENTERITIS 61 0.0042
514 MIDDLE INSOMNIA 78 0.0042
515 DYSPHONIA 244 0.0042
516 COUGH 1164 0.0041
517 MUSCULAR WEAKNESS 471 0.0041
518 DYSARTHRIA 156 0.0041
519 HYDRONEPHROSIS 31 0.0041
520 GASTRIC DISORDER 142 0.0041
521 EYE PAIN 233 0.0041
522 HYPOTENSION 826 0.0041
523 EAR PAIN 80 0.0041
524 SPUTUM DISCOLOURED 39 0.0041
525 CARDIOGENIC SHOCK 59 0.0041
526 MUSCLE ATROPHY 52 0.0041
527 ANXIETY 1168 0.0041
528 ACCIDENTAL OVERDOSE 150 0.0041
529 EATING DISORDER 87 0.0041
530 DRY MOUTH 330 0.0041
531 LOSS OF CONSCIOUSNESS 520 0.0041
532 ABDOMINAL PAIN 943 0.0040
533 RHINORRHOEA 262 0.0040
534 SKIN DISCOLOURATION 186 0.0040
535 ORAL DISCOMFORT 56 0.0040
536 RETINAL DETACHMENT 37 0.0040
537 HYPOTHYROIDISM 128 0.0040
538 PERIPHERAL COLDNESS 55 0.0040
539 LOW DENSITY LIPOPROTEIN INCREASED 31 0.0040
540 BLOOD PRESSURE DECREASED 266 0.0040
541 DRUG INTERACTION 633 0.0040
542 EYE DISORDER 131 0.0040
543 INSOMNIA 1061 0.0040
544 METASTASES TO LUNG 46 0.0040
545 BLINDNESS 162 0.0040
546 FULL BLOOD COUNT ABNORMAL 42 0.0040
547 IMPAIRED QUALITY OF LIFE 57 0.0040
548 SYNCOPE 396 0.0040
549 HYPOAESTHESIA 592 0.0040
550 FATIGUE 3076 0.0039
551 CYST 49 0.0039
552 MEMORY IMPAIRMENT 542 0.0039
553 PROTEINURIA 75 0.0039
554 HYPOKALAEMIA 182 0.0039
555 CHOLECYSTECTOMY 45 0.0039
556 PANCYTOPENIA 220 0.0039
557 WHITE BLOOD CELL COUNT INCREASED 151 0.0039
558 DRY THROAT 40 0.0039
559 METASTASES TO LIVER 69 0.0039
560 ROAD TRAFFIC ACCIDENT 164 0.0039
561 DEEP VEIN THROMBOSIS 254 0.0039
562 MYOSITIS 35 0.0039
563 INTESTINAL OBSTRUCTION 147 0.0039
564 BLISTER 219 0.0039
565 PNEUMONIA 1259 0.0039
566 DRUG ADMINISTRATION ERROR 119 0.0039
567 CONVULSION 221 0.0039
568 RASH GENERALISED 100 0.0039
569 PRODUCTIVE COUGH 184 0.0039
570 INJECTION SITE PAIN 1181 0.0038
571 SINUS CONGESTION 52 0.0038
572 FEEDING DISORDER 78 0.0038
573 PRODUCT QUALITY ISSUE 521 0.0038
574 RESPIRATORY RATE INCREASED 34 0.0038
575 DEMENTIA 107 0.0038
576 BURNING SENSATION 268 0.0038
577 HOT FLUSH 288 0.0038
578 AMNESIA 248 0.0038
579 VISUAL IMPAIRMENT 471 0.0038
580 KNEE ARTHROPLASTY 80 0.0038
581 RESTLESS LEGS SYNDROME 69 0.0038
582 SNEEZING 85 0.0038
583 HAEMATOCHEZIA 209 0.0038
584 SWOLLEN TONGUE 118 0.0038
585 UPPER-AIRWAY COUGH SYNDROME 31 0.0038
586 POOR QUALITY SLEEP 81 0.0038
587 PULMONARY THROMBOSIS 41 0.0038
588 CHEST DISCOMFORT 385 0.0038
589 EAR INFECTION 100 0.0038
590 INCORRECT DOSE ADMINISTERED 856 0.0037
591 NASAL CONGESTION 220 0.0037
592 HYPOKINESIA 54 0.0037
593 INJECTION SITE PRURITUS 249 0.0037
594 DYSPHAGIA 352 0.0037
595 PAIN IN JAW 105 0.0037
596 MYALGIA 630 0.0037
597 SCRATCH 39 0.0037
598 SPINAL DISORDER 35 0.0037
599 POST PROCEDURAL HAEMORRHAGE 43 0.0037
600 MELAENA 81 0.0037
601 SENSATION OF FOREIGN BODY 31 0.0037
602 SINUSITIS 376 0.0037
603 PLATELET COUNT DECREASED 391 0.0037
604 SEXUAL DYSFUNCTION 43 0.0037
605 HAEMATOMA 95 0.0037
606 GLOSSODYNIA 82 0.0037
607 OESOPHAGITIS 40 0.0037
608 NAIL DISORDER 32 0.0037
609 THERAPEUTIC RESPONSE UNEXPECTED 164 0.0037
610 NEOPLASM 42 0.0037
611 HIP FRACTURE 117 0.0036
612 INTENTIONAL PRODUCT MISUSE 318 0.0036
613 SINUS BRADYCARDIA 35 0.0036
614 SOMNOLENCE 728 0.0036
615 CHILLS 423 0.0036
616 EAR DISCOMFORT 37 0.0036
617 ABDOMINAL PAIN LOWER 91 0.0036
618 BASAL CELL CARCINOMA 56 0.0036
619 SPEECH DISORDER 188 0.0036
620 ULCER 57 0.0036
621 DIPLOPIA 93 0.0036
622 SWELLING 335 0.0036
623 PRESCRIBED OVERDOSE 69 0.0036
624 EYE DISCHARGE 37 0.0036
625 HYPONATRAEMIA 200 0.0035
626 HAEMATEMESIS 90 0.0035
627 NIGHT SWEATS 114 0.0035
628 PARAESTHESIA ORAL 51 0.0035
629 PRODUCT ODOUR ABNORMAL 37 0.0035
630 PALPITATIONS 412 0.0035
631 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 250 0.0035
632 CARDIAC FAILURE 280 0.0035
633 RESPIRATORY DISORDER 104 0.0035
634 BLOOD PRESSURE ABNORMAL 69 0.0035
635 BURSITIS 42 0.0035
636 GASTROINTESTINAL INFECTION 31 0.0035
637 THERAPY CHANGE 34 0.0035
638 PAIN 2123 0.0035
639 NEURALGIA 84 0.0035
640 GASTROINTESTINAL PAIN 38 0.0035
641 ABSCESS 55 0.0034
642 ELECTROLYTE IMBALANCE 40 0.0034
643 LACRIMATION INCREASED 104 0.0034
644 SKIN HAEMORRHAGE 51 0.0034
645 LIVER FUNCTION TEST ABNORMAL 100 0.0034
646 ARTHROPATHY 191 0.0034
647 THINKING ABNORMAL 64 0.0034
648 DIARRHOEA HAEMORRHAGIC 32 0.0034
649 OROPHARYNGEAL PAIN 313 0.0034
650 EMOTIONAL DISTRESS 408 0.0034
651 MOBILITY DECREASED 242 0.0034
652 LIP SWELLING 112 0.0034
653 PARAESTHESIA 528 0.0034
654 KNEE OPERATION 33 0.0034
655 DEVICE FAILURE 51 0.0033
656 INTENTIONAL DRUG MISUSE 70 0.0033
657 SWELLING FACE 218 0.0033
658 HEADACHE 2097 0.0033
659 IMPAIRED DRIVING ABILITY 38 0.0033
660 ASCITES 98 0.0033
661 JOINT SWELLING 401 0.0033
662 BRADYCARDIA 176 0.0033
663 INITIAL INSOMNIA 34 0.0033
664 PARANOIA 57 0.0033
665 PULMONARY FIBROSIS 63 0.0033
666 DELUSION 51 0.0033
667 BLOOD PRESSURE SYSTOLIC INCREASED 64 0.0033
668 JOINT RANGE OF MOTION DECREASED 44 0.0033
669 EYE SWELLING 122 0.0033
670 OXYGEN SATURATION DECREASED 184 0.0033
671 INFLUENZA 365 0.0033
672 MUSCLE TIGHTNESS 53 0.0033
673 SKIN DISORDER 109 0.0033
674 NASOPHARYNGITIS 602 0.0033
675 INJECTION SITE URTICARIA 80 0.0033
676 THROAT IRRITATION 146 0.0033
677 ALOPECIA 636 0.0032
678 RESPIRATORY DISTRESS 89 0.0032
679 PHARYNGITIS 40 0.0032
680 PRURITUS 1239 0.0032
681 COVID-19 PNEUMONIA 38 0.0032
682 MALIGNANT MELANOMA 43 0.0032
683 SKIN LESION 88 0.0032
684 PNEUMONIA ASPIRATION 80 0.0032
685 IMPAIRED HEALING 105 0.0032
686 HYPERBILIRUBINAEMIA 33 0.0032
687 POISONING 40 0.0032
688 CHOKING 62 0.0032
689 ARTHRALGIA 1320 0.0032
690 DEAFNESS 83 0.0032
691 MALAISE 1390 0.0032
692 INCORRECT DRUG ADMINISTRATION DURATION 89 0.0032
693 THERAPY CESSATION 162 0.0032
694 SCAR 54 0.0032
695 GINGIVAL BLEEDING 43 0.0031
696 URINARY RETENTION 105 0.0031
697 PARALYSIS 45 0.0031
698 IMPAIRED WORK ABILITY 67 0.0031
699 HALLUCINATION 236 0.0031
700 PLASMA CELL MYELOMA 122 0.0031
701 FIBROMYALGIA 76 0.0031
702 INCORRECT PRODUCT STORAGE 41 0.0031
703 WHEEZING 185 0.0031
704 BEDRIDDEN 41 0.0031
705 TASTE DISORDER 63 0.0031
706 ASPIRATION 34 0.0031
707 INJECTION SITE RASH 95 0.0031
708 BREAST PAIN 33 0.0031
709 DEVICE LEAKAGE 134 0.0031
710 DISABILITY 61 0.0031
711 GAIT INABILITY 103 0.0031
712 DENTAL CARIES 34 0.0031
713 LOWER LIMB FRACTURE 59 0.0031
714 EXPIRED PRODUCT ADMINISTERED 102 0.0031
715 SKIN CANCER 66 0.0031
716 RASH MACULAR 107 0.0031
717 BACTERIAL INFECTION 57 0.0031
718 WHITE BLOOD CELL COUNT DECREASED 331 0.0031
719 ABNORMAL DREAMS 84 0.0030
720 GASTRIC HAEMORRHAGE 35 0.0030
721 NO THERAPEUTIC RESPONSE 37 0.0030
722 ATAXIA 36 0.0030
723 CEREBRAL INFARCTION 74 0.0030
724 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 31 0.0030
725 ACCIDENT 36 0.0030
726 EXTRA DOSE ADMINISTERED 122 0.0030
727 JOINT STIFFNESS 79 0.0030
728 INSURANCE ISSUE 46 0.0030
729 WOUND 84 0.0030
730 TEMPERATURE INTOLERANCE 31 0.0030
731 WRIST FRACTURE 36 0.0030
732 LIVER DISORDER 133 0.0030
733 MUSCULOSKELETAL DISORDER 57 0.0030
734 BODY TEMPERATURE INCREASED 61 0.0030
735 BLOOD TEST ABNORMAL 42 0.0030
736 PHOTOPHOBIA 56 0.0030
737 LYMPHOMA 46 0.0030
738 MENTAL IMPAIRMENT 72 0.0030
739 TOOTH DISORDER 66 0.0030
740 ANGIOEDEMA 131 0.0030
741 HERPES ZOSTER 169 0.0029
742 BLOOD ALKALINE PHOSPHATASE INCREASED 73 0.0029
743 HEPATIC ENZYME INCREASED 200 0.0029
744 ACUTE HEPATIC FAILURE 40 0.0029
745 PRODUCT PHYSICAL ISSUE 59 0.0029
746 BONE PAIN 171 0.0029
747 SLEEP DISORDER 206 0.0029
748 OSTEOPOROSIS 120 0.0029
749 TINNITUS 134 0.0029
750 PLATELET COUNT INCREASED 38 0.0029
751 SPINAL PAIN 34 0.0029
752 FOOT DEFORMITY 32 0.0029
753 MENTAL DISORDER 125 0.0029
754 STOMATITIS 174 0.0029
755 RESPIRATORY ARREST 79 0.0029
756 MUSCLE TWITCHING 66 0.0029
757 ENCEPHALOPATHY 70 0.0028
758 DEVICE MECHANICAL ISSUE 39 0.0028
759 DRUG EFFECT INCOMPLETE 103 0.0028
760 HALLUCINATION, AUDITORY 45 0.0028
761 PULMONARY ARTERIAL HYPERTENSION 41 0.0028
762 EMOTIONAL DISORDER 87 0.0028
763 PULMONARY EMBOLISM 268 0.0028
764 DYSKINESIA 114 0.0028
765 MOVEMENT DISORDER 90 0.0028
766 APHONIA 39 0.0028
767 OBSTRUCTIVE AIRWAYS DISORDER 31 0.0028
768 TENDONITIS 43 0.0028
769 SURGERY 162 0.0028
770 SPINAL FRACTURE 55 0.0027
771 BLOOD CREATINE PHOSPHOKINASE INCREASED 79 0.0027
772 METASTASES TO BONE 45 0.0027
773 INTRAOCULAR PRESSURE INCREASED 35 0.0027
774 SEPTIC SHOCK 119 0.0027
775 DEVICE RELATED INFECTION 42 0.0027
776 INJECTION SITE DISCOLOURATION 34 0.0027
777 DRUG INEFFECTIVE 3585 0.0027
778 HEPATIC FAILURE 82 0.0027
779 DERMATITIS CONTACT 31 0.0027
780 VERTIGO 165 0.0027
781 RASH 1180 0.0027
782 DEVICE MALFUNCTION 190 0.0027
783 THROAT TIGHTNESS 73 0.0027
784 SPINAL OPERATION 33 0.0027
785 IRRITABILITY 161 0.0027
786 TOXICITY TO VARIOUS AGENTS 451 0.0027
787 VIRAL INFECTION 89 0.0027
788 HYPERCALCAEMIA 33 0.0027
789 HAEMORRHAGE 279 0.0027
790 PANIC ATTACK 97 0.0027
791 ASTHMA 298 0.0026
792 SECRETION DISCHARGE 33 0.0026
793 PROCEDURAL PAIN 73 0.0026
794 NIGHTMARE 91 0.0026
795 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 61 0.0026
796 APHASIA 79 0.0026
797 OCULAR HYPERAEMIA 124 0.0026
798 PSORIASIS 340 0.0026
799 DRUG PRESCRIBING ERROR 50 0.0026
800 ACUTE RESPIRATORY DISTRESS SYNDROME 46 0.0026
801 ILL-DEFINED DISORDER 158 0.0026
802 CEREBRAL HAEMORRHAGE 93 0.0026
803 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 142 0.0026
804 PRODUCT TASTE ABNORMAL 35 0.0026
805 LUNG DISORDER 126 0.0026
806 THERAPY INTERRUPTED 183 0.0026
807 SHOCK 58 0.0025
808 CLOSTRIDIUM DIFFICILE INFECTION 55 0.0025
809 IRRITABLE BOWEL SYNDROME 54 0.0025
810 THROMBOCYTOPENIA 281 0.0025
811 DISEASE PROGRESSION 297 0.0025
812 AGITATION 184 0.0025
813 SENSORY DISTURBANCE 40 0.0025
814 LIVER INJURY 61 0.0025
815 INCORRECT DOSE ADMINISTERED BY DEVICE 65 0.0025
816 INJECTION SITE ERYTHEMA 306 0.0025
817 PRODUCT DOSE OMISSION ISSUE 720 0.0024
818 ASPARTATE AMINOTRANSFERASE INCREASED 130 0.0024
819 LUNG INFECTION 38 0.0024
820 NEEDLE ISSUE 71 0.0024
821 ANGER 82 0.0024
822 CRYING 88 0.0024
823 HIP ARTHROPLASTY 37 0.0024
824 DEATH 2077 0.0024
825 TARDIVE DYSKINESIA 68 0.0024
826 DISCOMFORT 147 0.0024
827 SKIN FISSURES 47 0.0024
828 DEPRESSED MOOD 127 0.0024
829 INFECTION 347 0.0024
830 HYPERSENSITIVITY 444 0.0024
831 GASTROINTESTINAL DISORDER 214 0.0024
832 BRAIN OEDEMA 30 0.0024
833 CONDITION AGGRAVATED 718 0.0024
834 TACHYPNOEA 32 0.0024
835 NEOPLASM MALIGNANT 156 0.0023
836 DELIRIUM 81 0.0023
837 FREQUENT BOWEL MOVEMENTS 63 0.0023
838 COMA 111 0.0023
839 MUCOSAL INFLAMMATION 61 0.0023
840 RASH PAPULAR 52 0.0023
841 MANIA 38 0.0023
842 DISTURBANCE IN ATTENTION 124 0.0023
843 DRUG LEVEL INCREASED 38 0.0023
844 EYE IRRITATION 132 0.0023
845 INTENTIONAL DOSE OMISSION 65 0.0023
846 HYPERTHYROIDISM 33 0.0023
847 DEPRESSED LEVEL OF CONSCIOUSNESS 90 0.0023
848 URTICARIA 381 0.0023
849 HALLUCINATION, VISUAL 48 0.0023
850 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109 0.0023
851 TOOTH LOSS 47 0.0023
852 PYREXIA 784 0.0023
853 OSTEONECROSIS OF JAW 56 0.0023
854 ADVERSE REACTION 30 0.0023
855 DEVICE ISSUE 201 0.0022
856 EYE PRURITUS 75 0.0022
857 RESPIRATORY TRACT INFECTION 58 0.0022
858 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 104 0.0022
859 COORDINATION ABNORMAL 31 0.0022
860 PRODUCT USE ISSUE 417 0.0022
861 INJURY ASSOCIATED WITH DEVICE 45 0.0022
862 STEVENS-JOHNSON SYNDROME 49 0.0022
863 LYMPHADENOPATHY 78 0.0022
864 ILLNESS 227 0.0022
865 MUSCULOSKELETAL STIFFNESS 193 0.0022
866 ALANINE AMINOTRANSFERASE INCREASED 135 0.0022
867 APATHY 32 0.0022
868 JAUNDICE 59 0.0022
869 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 395 0.0022
870 PRODUCT DOSE OMISSION IN ERROR 62 0.0022
871 SKIN EXFOLIATION 183 0.0022
872 BLOOD PRESSURE FLUCTUATION 52 0.0022
873 LUNG NEOPLASM MALIGNANT 89 0.0022
874 ADVERSE DRUG REACTION 194 0.0022
875 PRODUCT USE COMPLAINT 34 0.0022
876 DERMATITIS 45 0.0021
877 RASH ERYTHEMATOUS 102 0.0021
878 ERYTHEMA 435 0.0021
879 BLOOD BILIRUBIN INCREASED 57 0.0021
880 DRY EYE 105 0.0021
881 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 71 0.0021
882 MOOD SWINGS 67 0.0021
883 HOSPITALISATION 321 0.0021
884 COLITIS 79 0.0021
885 ADVERSE EVENT 192 0.0021
886 MULTIPLE ORGAN DYSFUNCTION SYNDROME 59 0.0021
887 AGGRESSION 104 0.0021
888 ABNORMAL BEHAVIOUR 82 0.0021
889 TRANSAMINASES INCREASED 46 0.0021
890 PRODUCT SUBSTITUTION ISSUE 119 0.0021
891 FRACTURE 39 0.0021
892 BREAST CANCER FEMALE 55 0.0021
893 PHOTOSENSITIVITY REACTION 34 0.0021
894 NERVOUS SYSTEM DISORDER 64 0.0020
895 COVID-19 359 0.0020
896 INFLUENZA LIKE ILLNESS 167 0.0020
897 PNEUMONITIS 55 0.0020
898 BONE MARROW FAILURE 41 0.0020
899 PSYCHOTIC DISORDER 59 0.0020
900 SUICIDAL IDEATION 182 0.0020
901 PALLOR 54 0.0020
902 INTENTIONAL PRODUCT USE ISSUE 173 0.0020
903 DRY SKIN 261 0.0020
904 HEPATITIS 50 0.0020
905 HEAD DISCOMFORT 34 0.0019
906 BONE DENSITY DECREASED 60 0.0019
907 THERAPEUTIC RESPONSE DECREASED 116 0.0019
908 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 387 0.0019
909 PRESCRIBED UNDERDOSE 38 0.0019
910 HYPOCALCAEMIA 36 0.0019
911 TACHYCARDIA 168 0.0019
912 OFF LABEL USE 1653 0.0019
913 RESTLESSNESS 69 0.0019
914 FEMUR FRACTURE 58 0.0019
915 PELVIC PAIN 34 0.0019
916 THERAPY NON-RESPONDER 84 0.0019
917 LIVER FUNCTION TEST INCREASED 40 0.0019
918 APPLICATION SITE PAIN 41 0.0019
919 PSORIATIC ARTHROPATHY 75 0.0018
920 INCORRECT PRODUCT ADMINISTRATION DURATION 40 0.0018
921 MALIGNANT NEOPLASM PROGRESSION 189 0.0018
922 COGNITIVE DISORDER 85 0.0018
923 SEDATION 47 0.0018
924 PRODUCT PRESCRIBING ISSUE 39 0.0018
925 CANDIDA INFECTION 30 0.0018
926 INJECTION SITE SWELLING 136 0.0018
927 NEUTROPHIL COUNT DECREASED 72 0.0018
928 MOOD ALTERED 48 0.0018
929 PRODUCT AVAILABILITY ISSUE 40 0.0018
930 NEOPLASM PROGRESSION 61 0.0018
931 INJECTION SITE WARMTH 36 0.0017
932 DRUG INTOLERANCE 169 0.0017
933 PRODUCT DISPENSING ERROR 38 0.0017
934 PAIN OF SKIN 46 0.0017
935 PERITONITIS 35 0.0017
936 PRODUCT ADMINISTRATION ERROR 34 0.0017
937 DEVICE DELIVERY SYSTEM ISSUE 45 0.0016
938 INFLAMMATION 82 0.0016
939 ANAPHYLACTIC REACTION 87 0.0016
940 FEBRILE NEUTROPENIA 104 0.0016
941 MIGRAINE 143 0.0015
942 SEIZURE 173 0.0015
943 VAGINAL HAEMORRHAGE 65 0.0015
944 RASH MACULO-PAPULAR 33 0.0015
945 PRODUCT STORAGE ERROR 129 0.0015
946 MOUTH ULCERATION 31 0.0015
947 NEUTROPENIA 198 0.0015
948 HEPATOTOXICITY 32 0.0014
949 GENERAL PHYSICAL HEALTH DETERIORATION 164 0.0014
950 WITHDRAWAL SYNDROME 58 0.0014
951 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 98 0.0014
952 OVERDOSE 296 0.0014
953 PRODUCT USE IN UNAPPROVED INDICATION 340 0.0014
954 LEUKOPENIA 68 0.0014
955 RHEUMATOID ARTHRITIS 149 0.0013
956 INTENTIONAL OVERDOSE 83 0.0013
957 EXTRAPYRAMIDAL DISORDER 32 0.0013
958 HEPATIC FUNCTION ABNORMAL 48 0.0013
959 DISEASE RECURRENCE 60 0.0013
960 APPLICATION SITE ERYTHEMA 33 0.0013
961 SKIN BURNING SENSATION 90 0.0013
962 SUICIDE ATTEMPT 76 0.0013
963 INJECTION SITE REACTION 85 0.0012
964 INFUSION RELATED REACTION 80 0.0012
965 SYSTEMIC LUPUS ERYTHEMATOSUS 42 0.0012
966 DRUG-INDUCED LIVER INJURY 36 0.0011
967 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
968 ELECTROCARDIOGRAM QT PROLONGED 41 0.0011
969 PROSTATE CANCER 90 0.0011
970 INTERSTITIAL LUNG DISEASE 54 0.0011
971 RENAL CANCER 53 0.0011
972 MULTIPLE SCLEROSIS 53 0.0011
973 MULTIPLE SCLEROSIS RELAPSE 75 0.0011
974 PRODUCT ADHESION ISSUE 39 0.0011
975 OSTEONECROSIS 35 0.0011
976 NO ADVERSE EVENT 186 0.0010
977 SKIN IRRITATION 46 0.0010
978 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
979 BREAST CANCER 91 0.0010
980 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
981 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
982 ACCIDENTAL EXPOSURE TO PRODUCT 94 0.0009
983 COLITIS ULCERATIVE 40 0.0009
984 DERMATITIS ATOPIC 47 0.0009
985 DRUG WITHDRAWAL SYNDROME 76 0.0009
986 ACNE 65 0.0009
987 ECZEMA 44 0.0008
988 TREATMENT FAILURE 69 0.0008
989 DEVICE DISLOCATION 32 0.0007
990 DRUG DOSE OMISSION BY DEVICE 45 0.0006
991 DEVICE DIFFICULT TO USE 30 0.0005
992 DRUG DEPENDENCE 68 0.0004
993 DRUG ABUSE 34 0.0004